nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCB1—peripheral nervous system neoplasm	0.288	1	CbGaD
Mifepristone—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0694	0.12	CbGbCtD
Mifepristone—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0503	0.0869	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.046	0.0796	CbGbCtD
Mifepristone—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.046	0.0796	CbGbCtD
Mifepristone—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0428	0.0739	CbGbCtD
Mifepristone—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0392	0.0677	CbGbCtD
Mifepristone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0345	0.0597	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0267	0.0462	CbGbCtD
Mifepristone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0242	0.0418	CbGbCtD
Mifepristone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0242	0.0418	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0211	0.0365	CbGbCtD
Mifepristone—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0211	0.0365	CbGbCtD
Mifepristone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0168	0.029	CbGbCtD
Mifepristone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0159	0.0274	CbGbCtD
Mifepristone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0145	0.0251	CbGbCtD
Mifepristone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0145	0.025	CbGbCtD
Mifepristone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0135	0.0233	CbGbCtD
Mifepristone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0103	0.0178	CbGbCtD
Mifepristone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00962	0.0166	CbGbCtD
Mifepristone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00946	0.0163	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00645	0.0111	CbGbCtD
Mifepristone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00618	0.0107	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00608	0.0105	CbGbCtD
Mifepristone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00567	0.00979	CbGbCtD
Mifepristone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00386	0.00668	CbGbCtD
Mifepristone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000211	0.00158	CcSEcCtD
Mifepristone—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00157	CcSEcCtD
Mifepristone—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00157	CcSEcCtD
Mifepristone—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00021	0.00157	CcSEcCtD
Mifepristone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00021	0.00157	CcSEcCtD
Mifepristone—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00021	0.00157	CcSEcCtD
Mifepristone—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00157	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00156	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000208	0.00156	CcSEcCtD
Mifepristone—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00156	CcSEcCtD
Mifepristone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000208	0.00155	CcSEcCtD
Mifepristone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000208	0.00155	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000207	0.00155	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00154	CcSEcCtD
Mifepristone—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00154	CcSEcCtD
Mifepristone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000206	0.00154	CcSEcCtD
Mifepristone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000206	0.00154	CcSEcCtD
Mifepristone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000206	0.00154	CcSEcCtD
Mifepristone—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.00154	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.00153	CcSEcCtD
Mifepristone—Malaise—Etoposide—peripheral nervous system neoplasm	0.000204	0.00152	CcSEcCtD
Mifepristone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.00152	CcSEcCtD
Mifepristone—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00151	CcSEcCtD
Mifepristone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00151	CcSEcCtD
Mifepristone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000202	0.00151	CcSEcCtD
Mifepristone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000202	0.00151	CcSEcCtD
Mifepristone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00151	CcSEcCtD
Mifepristone—Infection—Cisplatin—peripheral nervous system neoplasm	0.0002	0.0015	CcSEcCtD
Mifepristone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0002	0.00149	CcSEcCtD
Mifepristone—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00149	CcSEcCtD
Mifepristone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000198	0.00148	CcSEcCtD
Mifepristone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.00148	CcSEcCtD
Mifepristone—Rash—Topotecan—peripheral nervous system neoplasm	0.000198	0.00148	CcSEcCtD
Mifepristone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000198	0.00148	CcSEcCtD
Mifepristone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000198	0.00148	CcSEcCtD
Mifepristone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000197	0.00148	CcSEcCtD
Mifepristone—Headache—Topotecan—peripheral nervous system neoplasm	0.000197	0.00147	CcSEcCtD
Mifepristone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000197	0.00147	CcSEcCtD
Mifepristone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000197	0.00147	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000197	0.00147	CcSEcCtD
Mifepristone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000196	0.00147	CcSEcCtD
Mifepristone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000196	0.00147	CcSEcCtD
Mifepristone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000196	0.00147	CcSEcCtD
Mifepristone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000196	0.00146	CcSEcCtD
Mifepristone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000196	0.00146	CcSEcCtD
Mifepristone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000195	0.00146	CcSEcCtD
Mifepristone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000195	0.00146	CcSEcCtD
Mifepristone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000195	0.00146	CcSEcCtD
Mifepristone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00146	CcSEcCtD
Mifepristone—Pain—Vincristine—peripheral nervous system neoplasm	0.000195	0.00146	CcSEcCtD
Mifepristone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000195	0.00146	CcSEcCtD
Mifepristone—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00146	CcSEcCtD
Mifepristone—Rash—Melphalan—peripheral nervous system neoplasm	0.000194	0.00145	CcSEcCtD
Mifepristone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000194	0.00145	CcSEcCtD
Mifepristone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00145	CcSEcCtD
Mifepristone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000192	0.00144	CcSEcCtD
Mifepristone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00143	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000191	0.00143	CcSEcCtD
Mifepristone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00019	0.00142	CcSEcCtD
Mifepristone—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00142	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00142	CcSEcCtD
Mifepristone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000188	0.00141	CcSEcCtD
Mifepristone—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00141	CcSEcCtD
Mifepristone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000188	0.0014	CcSEcCtD
Mifepristone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.0014	CcSEcCtD
Mifepristone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.0014	CcSEcCtD
Mifepristone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.0014	CcSEcCtD
Mifepristone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000187	0.0014	CcSEcCtD
Mifepristone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000186	0.00139	CcSEcCtD
Mifepristone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00139	CcSEcCtD
Mifepristone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000185	0.00139	CcSEcCtD
Mifepristone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000185	0.00139	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00137	CcSEcCtD
Mifepristone—Infection—Etoposide—peripheral nervous system neoplasm	0.000183	0.00137	CcSEcCtD
Mifepristone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000183	0.00137	CcSEcCtD
Mifepristone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000183	0.00137	CcSEcCtD
Mifepristone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00018	0.00135	CcSEcCtD
Mifepristone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00018	0.00135	CcSEcCtD
Mifepristone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00018	0.00134	CcSEcCtD
Mifepristone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000179	0.00134	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00132	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00132	CcSEcCtD
Mifepristone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000176	0.00132	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00131	CcSEcCtD
Mifepristone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000175	0.00131	CcSEcCtD
Mifepristone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.0013	CcSEcCtD
Mifepristone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.0013	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.0013	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000174	0.0013	CcSEcCtD
Mifepristone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000172	0.00129	CcSEcCtD
Mifepristone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000172	0.00129	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00128	CcSEcCtD
Mifepristone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.00127	CcSEcCtD
Mifepristone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000168	0.00125	CcSEcCtD
Mifepristone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.00125	CcSEcCtD
Mifepristone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000166	0.00124	CcSEcCtD
Mifepristone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000164	0.00123	CcSEcCtD
Mifepristone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000164	0.00123	CcSEcCtD
Mifepristone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000163	0.00122	CcSEcCtD
Mifepristone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00121	CcSEcCtD
Mifepristone—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00121	CcSEcCtD
Mifepristone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.00121	CcSEcCtD
Mifepristone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.00121	CcSEcCtD
Mifepristone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000161	0.0012	CcSEcCtD
Mifepristone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00016	0.0012	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000159	0.00119	CcSEcCtD
Mifepristone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000159	0.00119	CcSEcCtD
Mifepristone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000159	0.00119	CcSEcCtD
Mifepristone—Pain—Etoposide—peripheral nervous system neoplasm	0.000158	0.00118	CcSEcCtD
Mifepristone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000158	0.00118	CcSEcCtD
Mifepristone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000156	0.00117	CcSEcCtD
Mifepristone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000156	0.00117	CcSEcCtD
Mifepristone—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00114	CcSEcCtD
Mifepristone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000152	0.00114	CcSEcCtD
Mifepristone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000151	0.00113	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000151	0.00113	CcSEcCtD
Mifepristone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000151	0.00113	CcSEcCtD
Mifepristone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.00112	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00112	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00112	CcSEcCtD
Mifepristone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.00111	CcSEcCtD
Mifepristone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.00111	CcSEcCtD
Mifepristone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000148	0.00111	CcSEcCtD
Mifepristone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.00111	CcSEcCtD
Mifepristone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000147	0.0011	CcSEcCtD
Mifepristone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00109	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000146	0.00109	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000146	0.00109	CcSEcCtD
Mifepristone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00109	CcSEcCtD
Mifepristone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000145	0.00108	CcSEcCtD
Mifepristone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000144	0.00108	CcSEcCtD
Mifepristone—Rash—Vincristine—peripheral nervous system neoplasm	0.000144	0.00107	CcSEcCtD
Mifepristone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000143	0.00107	CcSEcCtD
Mifepristone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00107	CcSEcCtD
Mifepristone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00107	CcSEcCtD
Mifepristone—Headache—Vincristine—peripheral nervous system neoplasm	0.000143	0.00107	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00105	CcSEcCtD
Mifepristone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.00105	CcSEcCtD
Mifepristone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000138	0.00103	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000136	0.00102	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00101	CcSEcCtD
Mifepristone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000135	0.00101	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00101	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000992	CcSEcCtD
Mifepristone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000132	0.00099	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00099	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000988	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000981	CcSEcCtD
Mifepristone—Chills—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000977	CcSEcCtD
Mifepristone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000131	0.000976	CcSEcCtD
Mifepristone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000957	CcSEcCtD
Mifepristone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000954	CcSEcCtD
Mifepristone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000127	0.00095	CcSEcCtD
Mifepristone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000949	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000948	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000126	0.000944	CcSEcCtD
Mifepristone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000917	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000914	CcSEcCtD
Mifepristone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000122	0.000912	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000911	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000908	CcSEcCtD
Mifepristone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000904	CcSEcCtD
Mifepristone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000895	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000882	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000879	CcSEcCtD
Mifepristone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000117	0.000877	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000877	CcSEcCtD
Mifepristone—Rash—Etoposide—peripheral nervous system neoplasm	0.000116	0.00087	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000116	0.000869	CcSEcCtD
Mifepristone—Headache—Etoposide—peripheral nervous system neoplasm	0.000116	0.000864	CcSEcCtD
Mifepristone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000855	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000848	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000843	CcSEcCtD
Mifepristone—Nausea—Etoposide—peripheral nervous system neoplasm	0.00011	0.000819	CcSEcCtD
Mifepristone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000818	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000814	CcSEcCtD
Mifepristone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000807	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000807	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000804	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000801	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000797	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000791	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000789	CcSEcCtD
Mifepristone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000773	CcSEcCtD
Mifepristone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000768	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000758	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000757	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000751	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000746	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000746	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000744	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.000741	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.86e-05	0.000738	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000737	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.00073	CcSEcCtD
Mifepristone—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000723	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000716	CcSEcCtD
Mifepristone—Infection—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000711	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000705	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000702	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000699	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000695	CcSEcCtD
Mifepristone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000689	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.000688	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000682	CcSEcCtD
Mifepristone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000672	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.000669	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.000668	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.92e-05	0.000667	CcSEcCtD
Mifepristone—Constipation—Epirubicin—peripheral nervous system neoplasm	8.84e-05	0.000661	CcSEcCtD
Mifepristone—Pain—Epirubicin—peripheral nervous system neoplasm	8.84e-05	0.000661	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000652	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000647	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000638	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000637	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000636	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000632	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000622	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000618	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.000617	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.22e-05	0.000614	CcSEcCtD
Mifepristone—Pain—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000612	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000612	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000611	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000611	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.00059	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000585	CcSEcCtD
Mifepristone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.00057	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000568	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000566	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000566	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000555	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.32e-05	0.000547	CcSEcCtD
Mifepristone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.08e-05	0.000529	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.000527	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000513	CcSEcCtD
Mifepristone—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000511	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000506	CcSEcCtD
Mifepristone—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.58e-05	0.000492	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.55e-05	0.00049	CcSEcCtD
Mifepristone—Rash—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000488	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.51e-05	0.000487	CcSEcCtD
Mifepristone—Headache—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000484	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000473	CcSEcCtD
Mifepristone—Nausea—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000459	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000455	CcSEcCtD
Mifepristone—Rash—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000451	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000451	CcSEcCtD
Mifepristone—Headache—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000448	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000425	CcSEcCtD
